LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Charles Hsu will be a keynote speaker at the annual meeting of the Sino-American Pharmaceutical Association (West) in San Francisco
News | 04. 15. 2006
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.